- Home
- SANG vs CMPX Comparison
SANG vs CMPX Comparison
Compare SANG & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SANG
- CMPX
- Stock Information
- Founded
- SANG 1984
- CMPX 2014
- Country
- SANG Canada
- CMPX United States
- Employees
- SANG N/A
- CMPX N/A
- Industry
- SANG Computer Software: Programming Data Processing
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- SANG Technology
- CMPX Health Care
- Exchange
- SANG Nasdaq
- CMPX Nasdaq
- Market Cap
- SANG 235.6M
- CMPX 214.6M
- IPO Year
- SANG 2021
- CMPX N/A
- Fundamental
- Price
- SANG $7.01
- CMPX $2.00
- Analyst Decision
- SANG
- CMPX Strong Buy
- Analyst Count
- SANG 0
- CMPX 4
- Target Price
- SANG N/A
- CMPX $13.75
- AVG Volume (30 Days)
- SANG 7.6K
- CMPX 1.8M
- Earning Date
- SANG 02-06-2025
- CMPX 11-12-2024
- Dividend Yield
- SANG N/A
- CMPX N/A
- EPS Growth
- SANG N/A
- CMPX N/A
- EPS
- SANG N/A
- CMPX N/A
- Revenue
- SANG $244,406,000.00
- CMPX $850,000.00
- Revenue This Year
- SANG $3.36
- CMPX N/A
- Revenue Next Year
- SANG $7.39
- CMPX $613.39
- P/E Ratio
- SANG N/A
- CMPX N/A
- Revenue Growth
- SANG N/A
- CMPX N/A
- 52 Week Low
- SANG $2.50
- CMPX $0.77
- 52 Week High
- SANG $7.20
- CMPX $2.68
- Technical
- Relative Strength Index (RSI)
- SANG 57.08
- CMPX 65.48
- Support Level
- SANG $6.89
- CMPX $1.43
- Resistance Level
- SANG $7.15
- CMPX $2.68
- Average True Range (ATR)
- SANG 0.20
- CMPX 0.24
- MACD
- SANG -0.02
- CMPX 0.06
- Stochastic Oscillator
- SANG 51.28
- CMPX 46.87
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.